Archives for April 1, 2019

← 2019

New consultancy targets ‘expansive global landscape’ for cell and gene therapies

01-Apr-2019

By Melissa Fassbender

Cell One Partners formally launches its consulting services and aims to be a long-term partner to its clients, supporting the development of cell and gene therapies – a market which raised more than $13.3bn in 2018.

Yescarta to Europe: Steps learned and production 97% on-spec

01-Apr-2019

By Ben Hargreaves

The difficulties in the manufacture of CAR-T treatments have become increasingly understood as the breakthrough technology has been commercialised, but Kite’s head of medical affairs says its process is nearly flawless.